… ), the administration of minocycline was associated with the delay of disease progression.
In … huntingtin by minocycline and doxycycline was not associated with beneficial effects in …

… and pyruvate treatment reversed the neuronal insult produced by striatal injection of
quinolinic acid, an excito-toxic animal model of Huntington's disease. Inflammatory responses …

… This paper assesses in vivo cytotoxicity models of Huntington’s disease (HD). Nearly 150 …
cytotoxic induction of HD features in multiple rodent models. Typically, rodents are treated with …

… Alzheimer’s disease, Huntington's disease, Parkinson’s disease, Amyotrophic lateral …
effect of minocycline in several models of acute and chronic neurodegenerative disease like …

… readily crosses the blood-brain barrier with a rate of at least fivefold higher than doxycycline…
In one MPTP model, minocycline treatment blocked dopamine depletion in the nucleus …

… The research in animal AD/PD models provided evidence on … The neuroprotective effects
of minocycline and doxycycline … a long-standing doxycycline and minocycline therapy in these …

… This effect has been confirmed in experimental models of … including Parkinson's disease,
Huntington's disease, amyotrophic … as antibiotics are doxycycline and minocycline, which are …

… neuroprotective roles of minocycline and doxycycline in four … neurodegenerative disorders
(ALS, Huntington's disease, PD… In most CNS models the dose of minocycline required to …

… , with doxycycline taking its place and minocycline being currently … diseases and rheumatoid
arthritis. Among tetracyclines, … In an EAE animal model, minocycline reduced Tumor …

… absorption of minocycline and doxycycline does not appear … (12), although, oral doxycycline
and minocycline must be taken … pathways in models of Huntington's disease. Proceedings of …